IV Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of COVID19

ACR Open Rheumatology
doi 10.1002/acr2.11140
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Macrophage Activation Syndrome Associated With Adult-Onset Still’s Disease Successfully Treated With Anakinra

Case Reports in Rheumatology
2016English

High Systemic Levels of the Cytokine-Inducing HMGB1 Isoform Secreted in Severe Macrophage Activation Syndrome

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2014English

Evidence That Lipopolisaccharide May Contribute to the Cytokine Storm and Cellular Activation in Patients With Visceral Leishmaniasis

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2011English

The Calm After the Cytokine Storm: Lessons From the TGN1412 Trial

Journal of Clinical Investigation
Medicine
2008English

Anakinra for the Treatment of Adult-Onset Still’s Disease

Expert Review of Clinical Immunology
AllergyImmunology
2018English

AB0974 Etanercept Treatment for a Patient With Refractory Macrophage Activation Syndrome in Juvenile Systemic Lupus Erythematous

2017English

A New Shield for a Cytokine Storm

Cell
BiochemistryGeneticsMolecular Biology
2011English

Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

On the Alert for Cytokine Storm: Immunopathology in COVID-19

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy